Charles W. Newhall III - 21 Nov 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
21 Nov 2025
Net transactions value
+$194,700
Form type
4
Filing time
24 Nov 2025, 18:16:53 UTC
Previous filing
10 Oct 2025
Next filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
NEWHALL CHARLES W III Director C/O SUPERNUS PHARMACEUTICALS, INC.,, 9715 KEY WEST AVENUE, ROCKVILLE /s/ Timothy C. Dec, as attorney-in-fact 24 Nov 2025 0001005544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $194,700 +15,000 +14% $12.98 119,644 21 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Options Exercise $0 -15,000 -100% $0.000000 0 21 Nov 2025 Common Stock 15,000 $12.98 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.